Related Experiment Videos
[Neutropenia from oxacillin. 3 pediatric cases]
Pediatrie
|September 1, 1984
Summary
Oxacillin treatment can cause neutropenia (low white blood cell count) in children, appearing 18-24 days into therapy. Monitor blood cell counts weekly during oxacillin use to detect this adverse effect.
Area of Science:
- Pediatric Hematology
- Clinical Pharmacology
- Infectious Diseases
Background:
- Oxacillin is a penicillinase-resistant penicillin antibiotic commonly used to treat bacterial infections, particularly those caused by Staphylococcus species.
- Neutropenia, a condition characterized by abnormally low levels of neutrophils, can increase the risk of infection.
- Adverse drug reactions in pediatric populations require careful monitoring and documentation.
Observation:
- Three pediatric patients developed neutropenia during treatment with oxacillin.
- The onset of neutropenia occurred between 18 and 24 days after initiating oxacillin therapy at a dosage of 150 mg/kg/24 h.
- Associated symptoms included fever and skin rashes, suggesting a potential hypersensitivity or toxic reaction.
Findings:
- Oxacillin administration was associated with the development of neutropenia in pediatric patients.
- The timing of neutropenia suggests a subacute or delayed reaction to the antibiotic.
- Concurrent fever and rashes may serve as clinical indicators of this adverse event.
Implications:
- Weekly monitoring of complete blood counts is crucial for pediatric patients receiving oxacillin to enable early detection of neutropenia.
- Healthcare providers should be vigilant for signs of neutropenia, such as fever and rash, in children treated with oxacillin.
- This finding highlights the importance of pharmacovigilance for antibiotics in pediatric populations to ensure patient safety and optimize treatment outcomes.